SEC Form 4 · accession 0001144204-15-044519
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gordon A Troup
Director
Period of report
Jul 26, 2015
Accepted (ET)
Jul 28, 2015 · 11:20 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 26, 2015 | A | 10,559 | $1.61 | A | 232,314 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired from the Issuer in lieu of cash compensation for board and committee service during 2Q 2015.
- F2Reflects correction of 40 share understatement of shares beneficially owned on Form 4 filed on June 1, 2015.